Market, Research, Report, Business, Industry, Information, Automotive, Banking, Finance, Food, Beverages, Technology, Biomass, Books, Conference, Company Profiles, Country

 
 
  
    Your Comprehensive Resource
 For Market Research

   
   
 Home  Contact us

 Login



Search for Industry Sector, Market Sector, Company Profiles

  

   

        

 Follow Us !!!

 
 
   

Strategic Development of Neuronal Stem & Progenitor Cell Products

Published Date :  September 2011
 Add to Cart - Strategic Development of Neuronal Stem & Progenitor Cell Products 
 

neuronal stem cells

Overview: 

Neurogenesis is the process by which neurons are created. This process is most active during pre-natal development when neurogenesis is responsible for populating the growing brain. Neural stem cells (NSCs) are the self-renewing, multipotent cells that differentiate into the main phenotypes of the nervous system. These cell types include neurons, astrocytes, and oligodendrocytes. Neural progenitor cells (NPCs) are the progeny of stem cell division that normally undergo a limited number of replication cycles in vivo.
 

The terms neuronal and neural also need to be defined. Technically speaking, “neuronal” means “pertaining to neurons”, and “neural” means “pertaining to nerves, which are the cordlike bundles of fibers made up of neurons.” Since both terms ultimately are descriptive of neurons, the scientific community uses the terms "neuronal" and "neural" interchangeably. The complexity of this issue is explored from a marketing perspective within this report.
 

In 1992, Reynolds and Weiss were the first to isolate neural stem cells from the striatal tissue of adult mice brain tissue, including the subventricular zone, which is a neurogenic area. Since then, neural progenitor and stem cells have been isolated from various areas of the adult brain, including non-neurogenic areas like the spinal cord, and from other species, including humans. During the development of the nervous system, neural progenitor cells can either stay in the pool of proliferating undifferentiated cells or exit the cell cycle and differentiate.
 

Over the past few years, neuronal stem and progenitor cells have become of profound interest to the research community due to their potential to be used in drug discovery and delivery applications, as well as for tools of neural toxicology assessment. NSC transplantation also represents a ground-breaking approach for treating a range of chronic neurological diseases and acute CNS injuries, including Parkinson’s, Alzheimer’s and spinal cord injury, among other conditions.
 

This market report focuses on recent advances in NSC research applications, explores research priorities by market segment, highlights individual labs and end-users of neuronal stem cell research products, explores the competitive environment for NSC research products, and provides 5-year growth and trend analysis. It provides detailed guidance for companies that wish to offer strategically positioned NSC research products, including cells, kits, assays, and related media and reagents.

 

Table of Contents :

I. Background

A. Neuronal Stem & Progenitor Cells

B. Language Surrounding Neuronal Stem & Progenitor Cells

C. Regulation of Neuronal Stem & Progenitor Cells

D. Brief Product Background

II. Applications


A. Basic Research
1. Developmental Biology

2. Adult Biology
B. Drug Discovery Applications

C. Drug Delivery Applications

D. Neural Toxicology Assessment

E. Neural Transplantation

F. Brain Tumor Research


III. Application Priorities


A. Overall
1. Cell-Based Therapies: Greatest shared priority across research community

2. Standardized Neural Toxicology Assays: Deserve proportionally more attention

B. Breakdown of Neuronal Stem/Progenitor Cell Therapy, by Disorder


- Parkinson's
- Brain Tumor / Glioma
- Stroke
- Spinal Cord Injury
- Alzheimer's
- Other
- Huntington's
- Multiple Sclerosis (MS)
- Epilepsy
- Amyotrophic Lateral Sclerosis (ALS)
- Schizophrenia
- Cerebral Palsy

C. By Segment

1. Academic

2. Biotech

3. Pharma

IV. Patents


A. Key U.S. Neuronal Stem and Progenitor Cell Patents

B. Additional U.S. Patents

C. Additional European Patents


V. Projected 5-Year Market Growth


A. Scientific Publication Analysis

1. Neural vs. Neuronal Products
2. Stem vs. Progenitor Cell Products
3. Five-Year Growth Projections
4. Conclusions from Data

B. Grant Rate Analysis

1. Neural vs. Neuronal Products
2. Stem vs. Progenitor Cell Products
3. Five-Year Growth Projections
4. Conclusions from Data

C. Patent Analysis

1. Neural vs. Neuronal Products
2. Stem vs. Progenitor Cell Products
3. Five-Year Growth Projections
4. Conclusions from Data


VI. Competitors: Suppliers of Neuronal Stem & Progenitor Cell Products, including Products Offered

A. Millipore, Inc.

B. Stem Cell Technologies

C. AlphaGenix, Inc.

D. R&D Systems

E. Cell Applications

F. SA Biosciences

G. ScienCell

H. Neuromics

I. Amaxa

J. Invitrogen

K. Sigma Aldrich

L. Orion (no longer in existence)


VII. Specialty Pharmaceutical Companies: Neuronal Stem & Progenitor Cell Therapies

A. Neuralstem, Inc

B. NeuroNova AB

C. NeuroGeneration

VIII. Breakdown of Stem Cell Research Activity by Cell Type

- Embryonic SCs
- Hematopoietic SCs
- Mesenchymal SCs
- Neural Stem & Progenitor Cells
- Umbilical Cord SCs
- Cancer SCs
- Other SCs
- Fetal SCs

IX. Potential Labs/Customers


A. Academic Labs

B. Private Labs

C. Commercial Labs

D. Government Labs


X. Product Ideas & Suggestions


A. Product Categories

1. Cells & Tissue
a. Fetal-Derived Neural Stem Cells

b. Adult-Derived Neural Stem Cells

c. Fetal-Derived Immortalized Neural Stem Cells

d. Cryopreserved Embryonic Neurospheres

e. Embryonic Stem Cell Derived Neural Progenitors

f. Embryonic Primary Neuronal Tissue

g. NSC Differentiated Progeny Cells

2. Kits

a. Kits for Analysis of NSC Differentiated Progeny

b. Stem Cell Functional Kits

c. Neuronal Stem Cell Phenotyping Kits

d. Neural Stem Cell Expansion Kits

e. Neural Stem Cell Differentiation Kits

f. Neural Stem Cell Blotting Kits


3. Media: Maintenance, Differentiation, Expansion, & Freezing Medium

4. Growth Factors

5. Markets: Markers for Neural Stem Cells & Differentiated Progeny

6. PCR Arrays

7. Nucleofection Tools

8. Neural Toxicity Assessment


B. Product Suggestions
1. Neural Toxicity Assessment Products (an untapped niche)

2. Species-Specific Opportunities

3. Areas of Underdeveloped Competition

4. NSC Derived from Novel Sources

5. Neural Rosette Cells (R-NSCs)

 

Published By : BioInformant Worldwide, L.L.C.

 


Related Keywords: Energy, Insurance, Financial, Company Profile, Industry Profile, Swot Analysis, Apparel, Consumer, Trade, Information technology, Food, Healthcare, Construction, Retail, Design,Oil and Gas, Solar, Miscellaneous, Business, Pharmaceuticals, Technology, Defense, Medical, Travel, Power, Metal
 

  

 


PDF Format Reports will be
delivered by email within
12 to 24 hours after placing
 the order (Mon-Fri IST)

Australia Research Reports
Brazil Research Reports
Asia Research Reports
China Research Reports
Canada Research Reports
Europe Research Reports
France Research Reports
Egypt Research Reports
Global Research Reports
Greece Research Reports
Germany Research Reports
Japan Research Reports
India Research Reports
Ireland Research Reports

Korea Research Reports
Mexico Research Reports

Maldives Research Reports
New Zealand Research Reports
Netherland Research Reports
Poland Research Reports
Russia Research Reports
South Africa Research Reports
Sri Lanka Research Reports

Singapore Research Reports
Switzerland Research Reports  
UK Research Reports
USA Research Reports

UAE Research Reports
Uruguay Research Reports

ExxonMobil Company Analysis
Toyota Motors Company Analysis
ConocoPhillips Company Analysis
Sinopec Company Analysis
Total S.A. Company Analysis
Verizon Company Analysis
Gazprom Company Analysis
JPMorgan Company Analysis
Chevron Company Analysis
E.ON Company Analysis
PetroChina
Company Analysis
Allianz Company Analysis
AXA Company Analysis
Carrefour
Company Analysis
General Electric Company Analysis
Bank of America Company
Assicurazioni Generali Company
Samsung Electronics Company
GDF Suez Company Analysis
McKesson Corporation Company
Volkswagen Group Company
Royal Dutch Shell Company
 


 

 
 

Privacy Policy | Help/FAQ | Disclaimer | Sitemap | Resources | Research Blog | Feeds |  

Copyright © 2008 - 2012  trademark registered in India. All rights reserved.
Office Phone: (+91)
2227453309 | Telefax No: (+91) 2224169996
24/7 Online Support: (+91) 8149 85 2585 | Publishers contact: (+91) 8080 85 2585
Office Hours: 10:00 am to 6:00 pm (IST) Monday to Saturday

Email:
contact@aarkstore.com / customersupport@aarkstore.com